Table 3.
Subgroup analyses for the association between FBG and RPL
| Test for subgroup differences | |||||||
|---|---|---|---|---|---|---|---|
| Subgroup | No. of comparisons | MD (95%CI) | I2 (%) | P-value for heterogeneity | Chi2 | P | I2 (%) |
| Region | |||||||
| Asia | 7 | 2.48 [0.33, 4.63] | 91 | < 0.00001 | 6.31 | 0.18 | 36.6 |
| Africa | 2 | 11.63 [-7.58, 30.84] | 96 | < 0.00001 | |||
| Europe | 2 | -1.74 [-9.36, 5.88] | 88 | 0.003 | |||
| America | 2 | -1.08 [-4.24, 2.07] | 34 | 0.22 | |||
| Middle East | 6 | 3.49 [-0.15, 7.13] | 74 | 0.002 | |||
| Definition of RPL | |||||||
| > = 2 | 10 | 3.82 [1.17, 6.47] | 94 | < 0.00001 | 2.89 | 0.09 | 65.4 |
| > = 3 | 9 | 1.27 [0.00, 2.54] | 16 | 0.30 | |||
| Matched confounders | |||||||
| No | 8 | 1.09 [-0.84, 3.02] | 87 | < 0.00001 | 2.64 | 0.10 | 62.2 |
| Yes | 11 | 4.20 [0.98, 7.41] | 89 | < 0.00001 | |||
| Measurement timing | |||||||
| During pregnancy | 3 | 2.12 [-2.50, 6.73] | 88 | 0.0002 | 0.06 | 0.80 | 0 |
| Not during pregnancy | 16 | 2.75 [0.80, 4.70] | 88 | < 0.00001 | |||
| Exclusion of known factors | |||||||
| Yes | 14 | 2.66 [0.54, 4.77] | 9 | < 0.00001 | 0.02 | 0.89 | 0 |
| No | 5 | 2.88 [0.72, 5.03] | 62 | 0.03 | |||